JNJ
Johnson & Johnson · Healthcare · Drug Manufacturers - General
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss -0.1% · neue Nettopositionen -3.6% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 183 | +1 | 1.45B | $367.17B | +5 | −3 |
| Q1 2026 | 184 | 0 | 1.43B | $348.29B | +4 | −5 |
| Q4 2025 | 183 | 0 | 1.52B | $314.40B | +2 | −1 |
| Q3 2025 | 28 | 0 | 887.20M | $164.46B | — | −1 |
| Q2 2025 | 26 | +1 | 740.96M | $113.15B | +1 | — |
| Q1 2025 | 22 | -1 | 281.15M | $46.60B | — | −1 |
| Q4 2024 | 23 | +3 | 290.64M | $42.01B | +3 | — |
| Q3 2024 | 19 | -2 | 157.55M | $25.50B | — | −2 |
| Q2 2024 | 21 | — | 161.11M | $23.53B | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passiv) | 236.62M | -0.2% | $43.87B | 0.7% | ▼ Trim | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passiv) | 207.26M | +1.7% | $38.43B | 0.7% | ▲ Add | 2 | SEC ↗ ×22 |
| 3 | State Street Global Advisors ✦ (passiv) | 132.21M | -0.5% | $24.51B | 0.9% | ▼ Trim | 4 | SEC ↗ |
| 4 | JPMorgan Chase ✦ | 117.28M | — | $21.75B | 0.7% | n/c | 1 | SEC ↗ ×46 |
| 5 | Geode Capital Management ✦ (passiv) | 56.22M | -7.2% | $10.39B | 0.7% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | Morgan Stanley ✦ | 48.23M | — | $8.94B | 0.5% | n/c | 1 | SEC ↗ ×20 |
| 7 | Wellington Management ✦ | 25.83M | +3.8% | $4.79B | 0.8% | ▲ Add | 6 | SEC ↗ ×8 |
| 8 | Fidelity (FMR) ✦ | 13.44M | +0.2% | $2.49B | 0.1% | ▲ Add | 2 | SEC ↗ ×6 |
| 9 | Goldman Sachs Group ✦ | 13.11M | — | $2.43B | 0.4% | n/c | 1 | SEC ↗ ×6 |
| 10 | T. Rowe Price ✦ | 8.77M | +4.7% | $1.63B | 0.2% | ▲ Add | 6 | SEC ↗ ×2 |
| 11 | Fisher Asset Management ✦ | 8.45M | +2.1% | $1.57B | 0.6% | ▲ Add | 6 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 4.33M | -9.8% | $793.04M | 0.5% | ▼ Trim | 6 | SEC ↗ ×7 |
| 13 | Marshall Wace ✦ | 3.58M | +126.3% | $664.58M | 0.7% | ▲ Add | 6 | SEC ↗ ×3 |
| 14 | Arrowstreet Capital ✦ | 2.31M | -5.9% | $429.15M | 0.3% | ▼ Trim | 6 | SEC ↗ |
| 15 | Adage Capital Partners ✦ | 2.26M | +69.4% | $419.73M | 0.7% | ▲ Add | 6 | SEC ↗ |
| 16 | Bridgewater Associates ✦ | 1.72M | -24.8% | $318.14M | 1.2% | ▼ Trim | 6 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 1.33M | +138.6% | $246.64M | 0.2% | ▲ Add | 6 | SEC ↗ ×2 |
| 18 | D. E. Shaw & Co. ✦ | 1.14M | -59.8% | $212.06M | 0.2% | ▼ Trim | 6 | SEC ↗ ×2 |
| 19 | Two Sigma Investments ✦ | 925.29K | +422.8% | $171.57M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 20 | Millennium Management ✦ | 628.66K | -40.3% | $116.57M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 21 | Markel Group ✦ | 610.80K | 0.0% | $113.25M | 0.9% | Held | 6 | SEC ↗ ×2 |
| 22 | Renaissance Technologies ✦ | 306.75K | -65.3% | $56.88M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 23 | Tweedy, Browne ✦ | 242.00K | -1.1% | $44.87M | 3.9% | ▼ Trim | 6 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 213.04K | +15.6% | $39.50M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 25 | GAMCO Investors ✦ | 82.38K | -4.9% | $15.27M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 26 | Fairfax Financial ✦ | 73.40K | 0.0% | $13.61M | 0.7% | Held | 6 | SEC ↗ |
| 27 | Dodge & Cox ✦ | 20.95K | 0.0% | $3.88M | 0.0% | Held | 6 | SEC ↗ |
| 28 | Point72 Asset Management ✦ | 7.39K | -98.7% | $1.37M | 0.0% | ▼ Trim | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Norges Bank | $4.88B | war 0.6% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 1 Inhaber, 136.10K Anteile, $33,268 gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Käufe auf dem offenen Markt (P)
Keine Insider-Käufe auf dem offenen Markt in unserem Erfassungszeitraum.
Verkäufe auf dem offenen Markt (S)
Officer · 11.07K Ant. · $3.04M
Officer · 22.53K Ant. · $6.19M
Officer · 15.00K Ant. · $3.95M
Officer, Director · 102.31K Ant. · $26.70M
Officer, Director · 20.98K Ant. · $5.50M
Zuteilungen, Ausübungen und Steuereinbehalte werden hier nie als Käufe oder Verkäufe gezählt. Methodik
Big bank earnings arrive, with Citi, Goldman Sachs, JPMorgan Chase, and more reporting. Consumer and producer price…
Barrons